How long does it take for Ongentys to work?
Ongentys (opicapone) starts working quickly. Results from two large phase III trials showed that within one week of starting treatment with Ongentys it started working and significantly decreased mean off-time by 61 min for those receiving Ongentys 25 mg daily and 75 min for those receiving Ongentys 50 mg daily, compared with 23 min for those receiving placebo (p=0.0013, P<0.0001, respectively).
Further improvements were observed during the second and third week of treatment, after which the treatment effect stabilized. At the end of the 14-15 week study, a significant decrease in off-time of 93 min for Ongentys 25 mg recipients and 120 min of Ongentys 50 mg recipients was observed, compared with a 55 min decrease for placebo recipients (p=0.0091, p<0.001, respectively).
Ongentys is taken once daily at bedtime and is used to help people with Parkinson’s disease who are experiencing ‘off’ episodes (periods of time when their symptoms recur) while being treated with levodopa/carbidopa. It’s a COMT (catechol-O-methyltransferase) inhibitor, which helps to prevent off episodes by increasing the amount of levodopa that reaches the brain by blocking the COMT enzyme, which breaks down levodopa in the blood.
Related medical questions
- When is the best time to take Ongentys?
- Is Ongentys better than Comtan?
- How long does it take for Ongentys to work?
- When is the best time to take Ongentys?
- Is Ongentys better than Comtan?
- How long does it take for Ongentys to work?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions